NasdaqGM:ARDXBiotechs
Assessing Ardelyx (ARDX) Valuation After Recent Share Price Pullback And Growth Expectations
Ardelyx (ARDX) has drawn fresh attention after recent trading, with the stock down 24% over the past month and 13% over the past 3 months, prompting investors to reassess its current valuation.
See our latest analysis for Ardelyx.
At a share price of US$5.40, Ardelyx has seen pressure in the short term, with the 7 day share price return down 13.6% and the 30 day return down 24.3%, while the 1 year total shareholder return of 48.4% reflects a stronger longer term outcome.
If recent volatility...